Vascular-disrupting agents in oncology

Author： Mita Monica M Sargsyan Liza Mita Alain C Spear Matt

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.3, 2013-03, pp. : 317-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular Disrupting Agents (VDA) in Oncology: Advancing Towards New Therapeutic Paradigms in the Clinic

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2009-2015

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour targeting by microtubule-depolymerising vascular disrupting agents

By Kanthou Chryso Tozer Gillian M

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1443-1457

Informa Healthcare

Access to resources Recommend Favorite

Vascular Disrupting Agents (VDAs) in Anticancer Therapy

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 178-185

Bentham Science Publishers

Access to resources Recommend Favorite

New Vascular Disrupting Agents in Upper Gastrointestinal Malignancies

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-03 ,pp. : 1039-1049

Bentham Science Publishers

Access to resources Recommend Favorite

Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments

Current Medicinal Chemistry, Vol. 22, Iss. 11, 2015-04 ,pp. : 1348-1360

Bentham Science Publishers

Access to resources Recommend Favorite